- Home
- CYRX vs PGEN Comparison
CYRX vs PGEN Comparison
Compare CYRX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- PGEN
- Stock Information
- Founded
- CYRX 1999
- PGEN 1998
- Country
- CYRX United States
- PGEN United States
- Employees
- CYRX N/A
- PGEN N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CYRX Health Care
- PGEN Health Care
- Exchange
- CYRX Nasdaq
- PGEN Nasdaq
- Market Cap
- CYRX 310.4M
- PGEN 344.0M
- IPO Year
- CYRX N/A
- PGEN N/A
- Fundamental
- Price
- CYRX $5.55
- PGEN $1.39
- Analyst Decision
- CYRX Strong Buy
- PGEN Strong Buy
- Analyst Count
- CYRX 7
- PGEN 4
- Target Price
- CYRX $11.29
- PGEN $7.33
- AVG Volume (30 Days)
- CYRX 559.3K
- PGEN 1.5M
- Earning Date
- CYRX 05-06-2025
- PGEN 05-13-2025
- Dividend Yield
- CYRX N/A
- PGEN N/A
- EPS Growth
- CYRX N/A
- PGEN N/A
- EPS
- CYRX N/A
- PGEN N/A
- Revenue
- CYRX $228,385,000.00
- PGEN $3,925,000.00
- Revenue This Year
- CYRX N/A
- PGEN $318.39
- Revenue Next Year
- CYRX $5.30
- PGEN $789.17
- P/E Ratio
- CYRX N/A
- PGEN N/A
- Revenue Growth
- CYRX N/A
- PGEN N/A
- 52 Week Low
- CYRX $4.58
- PGEN $0.65
- 52 Week High
- CYRX $17.41
- PGEN $2.17
- Technical
- Relative Strength Index (RSI)
- CYRX 46.04
- PGEN 44.92
- Support Level
- CYRX $5.34
- PGEN $1.12
- Resistance Level
- CYRX $5.97
- PGEN $1.49
- Average True Range (ATR)
- CYRX 0.66
- PGEN 0.14
- MACD
- CYRX 0.02
- PGEN 0.00
- Stochastic Oscillator
- CYRX 38.82
- PGEN 63.64
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.